H.B. Fuller (FUL)
Market Price (7/15/2026): $56.02 | Market Cap: $3.1 BilSector: Materials | Industry: Specialty Chemicals
H.B. Fuller (FUL)
Market Price (7/15/2026): $56.02Market Cap: $3.1 BilSector: MaterialsIndustry: Specialty Chemicals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.5% Low stock price volatilityVol 12M is 34% Megatrend and thematic driversMegatrends include Advanced Materials, Circular Economy & Recycling, and Sustainable & Green Buildings. Themes include Specialty Chemicals for Performance, Show more. | Weak multi-year price returns2Y Excs Rtn is -60%, 3Y Excs Rtn is -87% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 64% Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -2.6%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -2.2%, Rev Chg QQuarterly Revenue Change % is -2.3% Key risksFUL key risks include [1] significant margin exposure to volatile raw material costs, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.5% |
| Low stock price volatilityVol 12M is 34% |
| Megatrend and thematic driversMegatrends include Advanced Materials, Circular Economy & Recycling, and Sustainable & Green Buildings. Themes include Specialty Chemicals for Performance, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -60%, 3Y Excs Rtn is -87% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 64% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -2.6%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -2.2%, Rev Chg QQuarterly Revenue Change % is -2.3% |
| Key risksFUL key risks include [1] significant margin exposure to volatile raw material costs, Show more. |
Qualitative Assessment
AI Analysis | Feedback
H.B. Fuller (FUL) stock has lost about 10% since 3/31/2026 because of the following key factors:
1. Market concerns regarding the acquisition of Advanced Medical Solutions Group plc (AMS) and increased leverage. H.B. Fuller announced an offer to acquire AMS for approximately GBP 715 million (around $1 billion), to be funded primarily through incremental debt. This transaction is expected to moderately improve the business profile but would result in a moderate leverage step-up, with Fitch estimating pro forma EBITDA leverage at approximately 4.7x, modestly exceeding Fitch's 4.5x negative rating sensitivity. Management committed to reducing leverage to its target range within two years, pausing share repurchases and additional mergers and acquisitions during this period. However, the market reacted negatively, with UBS cutting its price target due to acquisition concerns, and an activist investor condemning the deal.
2. Persistent macroeconomic headwinds and overcapacity in the broader chemical industry. The global chemical industry faced a challenging environment in 2026, characterized by overcapacity, soft demand, and geopolitical uncertainties. Global chemical production was projected to grow by a modest 0.5% in 2026, while specialty chemical output, a key segment for H.B. Fuller, was expected to decline slightly by 0.3% due to weak market demand. This industry-wide downturn likely placed downward pressure on H.B. Fuller's stock, irrespective of company-specific performance, as demand remained uneven in key end markets and overcapacity squeezed profit margins.
Show more
H.B. Fuller (FUL) stock has lost about 10% since 3/31/2026 because of the following key factors:
1. Market concerns regarding the acquisition of Advanced Medical Solutions Group plc (AMS) and increased leverage. H.B. Fuller announced an offer to acquire AMS for approximately GBP 715 million (around $1 billion), to be funded primarily through incremental debt. This transaction is expected to moderately improve the business profile but would result in a moderate leverage step-up, with Fitch estimating pro forma EBITDA leverage at approximately 4.7x, modestly exceeding Fitch's 4.5x negative rating sensitivity. Management committed to reducing leverage to its target range within two years, pausing share repurchases and additional mergers and acquisitions during this period. However, the market reacted negatively, with UBS cutting its price target due to acquisition concerns, and an activist investor condemning the deal.
2. Persistent macroeconomic headwinds and overcapacity in the broader chemical industry. The global chemical industry faced a challenging environment in 2026, characterized by overcapacity, soft demand, and geopolitical uncertainties. Global chemical production was projected to grow by a modest 0.5% in 2026, while specialty chemical output, a key segment for H.B. Fuller, was expected to decline slightly by 0.3% due to weak market demand. This industry-wide downturn likely placed downward pressure on H.B. Fuller's stock, irrespective of company-specific performance, as demand remained uneven in key end markets and overcapacity squeezed profit margins.
3. Investor skepticism regarding the durability of H.B. Fuller's recovery and ambitious full-year guidance. Despite reporting adjusted diluted EPS of $1.41 for fiscal Q2 2026, which ended May 30, 2026, and beating consensus estimates, the market experienced an approximately 8.4% selloff in the stock post-earnings. This reaction suggested investor concern that the reported profitability gains were largely driven by pricing execution and restructuring savings, rather than robust volume growth, as organic revenue grew by only 2.6% year-on-year. Furthermore, the company's full-year fiscal 2026 adjusted EPS guidance, while increased at the midpoint to a range of $4.60 to $4.90, appeared ambitious to some investors, implying a significant acceleration needed in the second half of the year, especially given prior guidance misses.
Show less
Stock Movement Drivers
Fundamental Drivers
The -8.8% change in FUL stock from 3/31/2026 to 7/14/2026 was primarily driven by a -8.8% change in the company's P/E Multiple.| (LTM values as of) | 3312026 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 61.43 | 56.02 | -8.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 3,456 | 3,456 | 0.0% |
| Net Income Margin (%) | 4.6% | 4.6% | 0.0% |
| P/E Multiple | 21.0 | 19.2 | -8.8% |
| Shares Outstanding (Mil) | 55 | 55 | 0.0% |
| Cumulative Contribution | -8.8% |
Market Drivers
3/31/2026 to 7/14/2026| Return | Correlation | |
|---|---|---|
| FUL | -8.8% | |
| Market (SPY) | 15.6% | 33.0% |
| Sector (XLB) | 1.3% | 61.8% |
Fundamental Drivers
The -5.1% change in FUL stock from 12/31/2025 to 7/14/2026 was primarily driven by a -31.4% change in the company's P/E Multiple.| (LTM values as of) | 12312025 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 59.01 | 56.02 | -5.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 3,502 | 3,456 | -1.3% |
| Net Income Margin (%) | 3.3% | 4.6% | 40.9% |
| P/E Multiple | 28.0 | 19.2 | -31.4% |
| Shares Outstanding (Mil) | 54 | 55 | -0.6% |
| Cumulative Contribution | -5.1% |
Market Drivers
12/31/2025 to 7/14/2026| Return | Correlation | |
|---|---|---|
| FUL | -5.1% | |
| Market (SPY) | 10.6% | 35.8% |
| Sector (XLB) | 12.2% | 67.5% |
Fundamental Drivers
The -5.4% change in FUL stock from 6/30/2025 to 7/14/2026 was primarily driven by a -38.6% change in the company's P/E Multiple.| (LTM values as of) | 6302025 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 59.21 | 56.02 | -5.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 3,528 | 3,456 | -2.0% |
| Net Income Margin (%) | 2.9% | 4.6% | 58.2% |
| P/E Multiple | 31.3 | 19.2 | -38.6% |
| Shares Outstanding (Mil) | 54 | 55 | -0.5% |
| Cumulative Contribution | -5.4% |
Market Drivers
6/30/2025 to 7/14/2026| Return | Correlation | |
|---|---|---|
| FUL | -5.4% | |
| Market (SPY) | 22.7% | 35.8% |
| Sector (XLB) | 17.0% | 70.7% |
Fundamental Drivers
The -18.4% change in FUL stock from 6/30/2023 to 7/14/2026 was primarily driven by a -19.1% change in the company's P/E Multiple.| (LTM values as of) | 6302023 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 68.67 | 56.02 | -18.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 3,607 | 3,456 | -4.2% |
| Net Income Margin (%) | 4.4% | 4.6% | 6.1% |
| P/E Multiple | 23.7 | 19.2 | -19.1% |
| Shares Outstanding (Mil) | 54 | 55 | -0.8% |
| Cumulative Contribution | -18.4% |
Market Drivers
6/30/2023 to 7/14/2026| Return | Correlation | |
|---|---|---|
| FUL | -18.4% | |
| Market (SPY) | 75.6% | 49.8% |
| Sector (XLB) | 29.0% | 71.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| FUL Return | 58% | -11% | 15% | -16% | -10% | -5% | 16% |
| Peers Return | 26% | -18% | 2% | -5% | -0% | 12% | 13% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 10% | 100% |
Monthly Win Rates [3] | |||||||
| FUL Win Rate | 75% | 50% | 42% | 42% | 42% | 43% | |
| Peers Win Rate | 60% | 42% | 52% | 50% | 43% | 63% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 57% | |
Max Drawdowns [4] | |||||||
| FUL Max Drawdown | -14% | -27% | -15% | -22% | -28% | -27% | |
| Peers Max Drawdown | -16% | -35% | -31% | -26% | -32% | -23% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ASH, NGVT, HUN, SHW, ECL. See FUL Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/14/2026 (YTD)
How Low Can It Go
| Event | FUL | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -18.0% | -18.8% |
| % Gain to Breakeven | 21.9% | 23.1% |
| Time to Breakeven | 79 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -12.2% | -9.5% |
| % Gain to Breakeven | 13.9% | 10.5% |
| Time to Breakeven | 18 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -12.1% | -6.7% |
| % Gain to Breakeven | 13.7% | 7.1% |
| Time to Breakeven | 33 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -24.9% | -24.5% |
| % Gain to Breakeven | 33.2% | 32.4% |
| Time to Breakeven | 127 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -47.0% | -33.7% |
| % Gain to Breakeven | 88.6% | 50.9% |
| Time to Breakeven | 135 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -21.6% | -19.2% |
| % Gain to Breakeven | 27.6% | 23.8% |
| Time to Breakeven | 65 days | 105 days |
In The Past
H.B. Fuller's stock fell -18.0% during the 2025 US Tariff Shock. Such a loss loss requires a 21.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | FUL | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -24.9% | -24.5% |
| % Gain to Breakeven | 33.2% | 32.4% |
| Time to Breakeven | 127 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -47.0% | -33.7% |
| % Gain to Breakeven | 88.6% | 50.9% |
| Time to Breakeven | 135 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -21.6% | -19.2% |
| % Gain to Breakeven | 27.6% | 23.8% |
| Time to Breakeven | 65 days | 105 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -29.6% | -6.8% |
| % Gain to Breakeven | 42.0% | 7.3% |
| Time to Breakeven | 247 days | 15 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -29.3% | -17.9% |
| % Gain to Breakeven | 41.5% | 21.8% |
| Time to Breakeven | 99 days | 123 days |
| 2010 Eurozone Sovereign Debt Crisis / Flash Crash | ||
| % Loss | -22.8% | -15.4% |
| % Gain to Breakeven | 29.5% | 18.2% |
| Time to Breakeven | 356 days | 125 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -59.2% | -53.4% |
| % Gain to Breakeven | 145.0% | 114.4% |
| Time to Breakeven | 307 days | 1085 days |
In The Past
H.B. Fuller's stock fell -18.0% during the 2025 US Tariff Shock. Such a loss loss requires a 21.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About H.B. Fuller (FUL)
H.B. Fuller Company (FUL) is a global specialty chemicals manufacturer that develops, produces, and markets a wide array of industrial materials. At its core, the company provides essential bonding and protective solutions, including adhesives, sealants, coatings, and polymers, which are critical components in manufacturing countless products worldwide. These specialized chemical solutions enable product assembly, enhance durability, and improve performance across diverse sectors.
The company operates through three main segments. Its Hygiene, Health and Consumable Adhesives segment supplies a variety of thermoplastic, thermoset, and water-based adhesives crucial for high-volume applications such as food packaging, consumer goods like disposable diapers and feminine care products, as well as paper converting and flexible packaging. Complementing this, the Engineering Adhesives segment focuses on high-performance industrial adhesives, including reactive, silicone, and polyurethane formulations, which are vital for demanding industries like transportation, electronics, medical devices, aerospace, and general industrial applications such as appliances, windows, and heavy machinery.
Finally, H.B. Fuller's Construction Adhesives segment offers products tailored for the building and construction industry. This includes materials for tile setting, commercial roofing, HVAC insulation, and a range of caulks and sealants. These products serve both professional contractors and the consumer market, underpinning construction projects globally. The company distributes its extensive portfolio of products directly, as well as through a network of distributors and retailers worldwide.
AI Analysis | Feedback
Analogies for H.B. Fuller (FUL):
- Like 3M, but specialized entirely in industrial and consumer adhesives, sealants, and coatings for products worldwide.
- Think of them as a massive, industrial-scale Loctite, providing specialized glues and bonding solutions for everything from disposable diapers to aerospace components.
AI Analysis | Feedback
- Adhesives: Chemical compounds formulated to bond materials together across diverse industries, including consumer goods, packaging, and construction.
- Sealants: Materials used to fill gaps, block fluids, and provide protective barriers in construction and industrial applications.
- Coatings: Specialty formulations applied to surfaces for protection, aesthetics, or specific functional properties.
- Polymers: Fundamental chemical building blocks used in the creation of many of their other specialty products.
- Tapes: Adhesive-backed flexible materials for joining, fastening, or sealing applications.
- Encapsulants: Materials used to encase and protect sensitive electronic or other components.
- Additives: Chemicals incorporated to enhance the performance or characteristics of other products.
AI Analysis | Feedback
H.B. Fuller (symbol: FUL) primarily sells its specialty chemical products, including adhesives, sealants, coatings, and polymers, to other companies across a wide range of industries (B2B). The company's provided description does not disclose the names of its specific major customer companies. Instead, its customers are generally manufacturers and businesses that utilize FUL's products as components in their own manufacturing processes or for professional applications. These customer categories include:
- Manufacturers of Consumer Goods and Packaging: This category encompasses companies that produce a vast array of everyday items and their associated packaging. Applications include food and beverage containers, flexible packaging, various consumer goods (such as disposable diapers, feminine care products, medical garments, health and beauty products), and paper converting products (e.g., corrugation, folding cartons, labels, envelopes, books, multi-wall bags, sacks, tissue, and towel products).
- Manufacturers of Industrial and Engineered Products: These are companies in sectors requiring high-performance adhesives and sealants for their specialized products. This category includes manufacturers of appliances, filters, windows, doors, wood flooring, textiles, transportation equipment (including automotive, aerospace, and defense applications), electronics, medical devices, clean energy components, heavy machinery, and insulating glass units.
- Construction and Building Materials Companies: This category includes businesses involved in commercial and residential construction projects. Their applications for H.B. Fuller's products include tile setting, commercial roofing, heating, ventilation, and air conditioning (HVAC) and insulation. This segment also serves the professional trade and consumer markets (via retailers) for caulks and sealants used in various building and repair projects.
AI Analysis | Feedback
AI Analysis | Feedback
Celeste Mastin, President and Chief Executive Officer
Celeste Mastin was appointed President and Chief Executive Officer of H.B. Fuller in December 2022, after serving as Executive Vice President and Chief Operating Officer from March to December 2022. She has over 30 years of experience in manufacturing and distribution, with a history of guiding company growth through innovation, service improvement, global expansion, and acquisitions. Before joining H.B. Fuller, Ms. Mastin was the CEO and a board member at PetroChoice Lubrication Solutions from 2018 to 2022. She also held CEO roles at Distribution International, Inc. (2013-2017) and MMI Products, Inc. (a division of Oldcastle) (2007-2011). Additionally, she held senior leadership positions at Ferro Corporation (2003-2007) and Bostik Adhesives. Ms. Mastin began her career at Shell Chemical Co.
John Corkrean, Executive Vice President and Chief Financial Officer
John Corkrean has served as Executive Vice President and Chief Financial Officer of H.B. Fuller since May 2016. Prior to joining H.B. Fuller, Mr. Corkrean had a 17-year career at Ecolab Inc., where he held various finance leadership roles, including Senior Vice President, Finance – Global Energy Services, Senior Vice President and Corporate Controller, and Vice President and Treasurer. He was also instrumental in the integration of the Nalco and Champion acquisitions at Ecolab. Before Ecolab, he was Manager, Corporate Treasury at Kellogg Company from 1997 to 1999, and held various finance positions at Amoco Corporation from 1989 to 1997.
Gregory Ogunsanya, Senior Vice President, General Counsel, and Corporate Secretary
Gregory Ogunsanya joined H.B. Fuller as Senior Vice President, General Counsel, and Corporate Secretary in October 2023. Before H.B. Fuller, he held dual legal leadership roles as Vice President of Legal for Stanley Industrial and Assistant General Counsel, Securities, and Governance at Stanley Black & Decker Inc. He also held various leadership positions at Honeywell Inc., including General Counsel of Honeywell Industrial Safety and General Legal Counsel of the Honeywell Electronic Solutions, Engines, and Power Systems business unit.
Heather Campe, Senior Vice President, International Growth
Heather Campe assumed the role of Senior Vice President, International Growth, in December 2021. During her 13-year career with H.B. Fuller, she has also served as Senior Vice President, Global Hygiene, Health, and Consumable Adhesives (2019-2021); Senior Vice President, Americas Adhesives (2016-2019); and Vice President, Asia Pacific (2013-2016). Prior to joining H.B. Fuller, Ms. Campe held roles of increasing responsibility at National Adhesives (now Henkel Corporation) from 1995-2009.
Jim East, Executive Vice President, Hygiene, Health and Consumable Adhesives
Jim East assumed the role of Executive Vice President, Hygiene, Health and Consumable Adhesives in 2022. He joined H.B. Fuller in 2016 as part of the Cyberbond acquisition. Within H.B. Fuller, he has held roles such as Senior Vice President, Hygiene, Health and Consumable Adhesives; Vice President, Engineering Adhesives – Americas; and Global Director, Automotive.
AI Analysis | Feedback
The key risks to H.B. Fuller's business include:
- Raw Material Cost Volatility: H.B. Fuller faces significant exposure to fluctuations in the cost and availability of raw materials, which comprise approximately 75% of its cost of sales. Spikes in raw material costs can erode profit margins if the company cannot effectively or quickly pass these increased costs on to customers through pricing actions.
- High Leverage: The company operates with a relatively high net debt-to-EBITDA ratio, which is above the market average. This elevated leverage increases financial risk and could reduce the company's flexibility, particularly during an economic downturn or if interest rates rise. The terms of upcoming debt maturities and refinancing will be key indicators of balance sheet risk.
- Intense Competition and Economic Cyclicality: H.B. Fuller operates in a highly competitive global adhesives market, where numerous large chemical companies and specialized players vie for market share. This competitive intensity can lead to pricing pressures and limit organic growth. Furthermore, demand for its products is closely tied to global economic health and cyclical end markets such as construction, packaging, and durable goods, making the company vulnerable to economic downturns that can impact revenue and volumes.
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
H.B. Fuller (FUL) anticipates several key drivers for future revenue growth over the next two to three years, stemming from strategic initiatives, market positioning, and anticipated market recoveries.
One significant driver is **strategic acquisitions and ongoing portfolio optimization**. H.B. Fuller has indicated that its mergers and acquisitions (M&A) strategy is an "EBITDA compounder" designed to fuel future growth. This includes strategic acquisitions, particularly in areas like medical adhesives and fastener technology, which have already contributed to strong growth in the Engineering Adhesives segment. The company has also engaged in portfolio adjustments, such as the divestiture of its flooring business, to reposition for higher-growth opportunities.
Another expected driver is **expansion and market share gains within high-growth adhesives markets**. The company aims to increase its market share in faster-growing, higher-margin segments, building on its current 6.0% share. Specific areas targeted for growth include packaging, medical, flexible packaging, solar, automotive, and electronics. H.B. Fuller's packaging business, for example, has demonstrated strong volume growth and a strategy of creating solutions and expanding into new distribution channels.
A third driver is **targeted pricing actions coupled with volume recovery in key end markets**. While organic revenue has seen modest growth in recent periods, the company has successfully implemented targeted pricing actions across all three of its global business units, contributing to margin expansion. Furthermore, H.B. Fuller expects volume growth to contribute to revenue as destocking activities in segments like Hygiene, Health, and Consumable Adhesives (HHC) conclude, and as the construction sector prepares for a normal season. Strong performance in construction adhesives is also noted as an ongoing contributor.
AI Analysis | Feedback
Share Repurchases
- H.B. Fuller repurchased approximately 1 million shares in fiscal year 2025, including 300,000 shares in Q2 FY2025. The total dollar value of share repurchases in 2025 was $60.713 million.
- The company's annual share repurchases amounted to $39.558 million in 2024 and $2.567 million in 2023.
- As of January 22, 2026, H.B. Fuller had completed the repurchase of 1,384,937 shares for $88.74 million under a buyback plan announced on April 7, 2022. There were no repurchases under this program in 2021 and 2022.
Share Issuance
- For fiscal year 2026, the average diluted share count is expected to be between 55 million and 56 million shares, with share repurchases offsetting shares issued through compensation plans.
Outbound Investments
- In 2025, H.B. Fuller executed several acquisitions in medical adhesives and fastener coating systems, including completing the acquisitions of GEM S.r.l. and Medifill Ltd., which are formulators, manufacturers, and marketers of medical-grade adhesives.
- In 2024, the company acquired CutisSeal, a medical device company. They also acquired Hsbutyl and ND Industries.
- In 2023, H.B. Fuller completed two strategic acquisitions: Adhezion Biomedical, a U.S. medical adhesives business, and XCHEM International, an adhesives manufacturer in the United Arab Emirates. These acquisitions were expected to contribute approximately $17 million to sales revenue and $2 million to adjusted EBITDA in fiscal 2023. Other acquisitions in 2023 included Sanglier, Beardow Adams, and Lemtapes. The company also acquired Apollo Chemicals for $211 million in January 2022.
Capital Expenditures
- H.B. Fuller projects capital expenditures of approximately $160 million for fiscal year 2026, with about $50 million specifically allocated to manufacturing footprint consolidation.
- For fiscal year 2025, capital expenditures were initially expected to be $150 million, later revised to approximately $140 million.
- The primary focus of capital expenditures includes a multi-year plan to streamline its manufacturing and supply chain footprint, aiming to reduce manufacturing facilities from 82 to 55 by 2030 and North American warehouses from 55 to approximately 10 by 2027, with an expected incremental investment of about $150 million over five years.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 69.84 |
| Mkt Cap | 3.1 |
| Rev LTM | 4,602 |
| Op Inc LTM | 330 |
| FCF LTM | 222 |
| FCF 3Y Avg | 177 |
| CFO LTM | 308 |
| CFO 3Y Avg | 309 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -2.3% |
| Rev Chg 3Y Avg | -5.5% |
| Rev Chg Q | 2.4% |
| QoQ Delta Rev Chg LTM | 0.5% |
| Op Inc Chg LTM | 0.1% |
| Op Inc Chg 3Y Avg | 5.1% |
| Op Mgn LTM | 13.6% |
| Op Mgn 3Y Avg | 13.3% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 15.5% |
| CFO/Rev 3Y Avg | 15.0% |
| FCF/Rev LTM | 11.2% |
| FCF/Rev 3Y Avg | 9.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 3.1 |
| P/S | 1.9 |
| P/Op Inc | 23.3 |
| P/EBIT | 1.6 |
| P/E | 7.4 |
| P/CFO | 11.9 |
| Total Yield | -0.4% |
| Dividend Yield | 1.0% |
| FCF Yield 3Y Avg | 3.8% |
| D/E | 0.5 |
| Net D/E | 0.4 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 1.6% |
| 3M Rtn | -3.0% |
| 6M Rtn | 2.4% |
| 12M Rtn | 5.6% |
| 3Y Rtn | 1.8% |
| 1M Excs Rtn | 0.2% |
| 3M Excs Rtn | -12.4% |
| 6M Excs Rtn | -6.9% |
| 12M Excs Rtn | -15.3% |
| 3Y Excs Rtn | -67.0% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Hygiene, Health and Consumable Adhesives | 1,552 | 1,546 | 1,601 | 1,696 | 1,473 |
| Engineering Adhesives | 1,062 | 1,459 | 1,429 | 1,533 | 1,372 |
| Building Adhesive Solutions | 860 | ||||
| Corporate Unallocated | 0 | ||||
| Construction Adhesives | 563 | 481 | 521 | 434 | |
| Total | 3,474 | 3,569 | 3,511 | 3,749 | 3,278 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Engineering Adhesives | 193 | 187 | 169 | 136 | 104 |
| Hygiene, Health and Consumable Adhesives | 187 | 215 | 166 | 138 | 131 |
| Construction Adhesives | 25 | 6 | 23 | 14 | 11 |
| Corporate Unallocated | -58 | -53 | -35 | -36 | -28 |
| Total | 348 | 355 | 323 | 253 | 218 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Hygiene, Health and Consumable Adhesives | 1,963 | 1,611 | 1,661 | 1,488 | 1,371 |
| Engineering Adhesives | 1,566 | 1,534 | 1,628 | 1,610 | 1,710 |
| Building Adhesive Solutions | 1,189 | 1,240 | |||
| Corporate Unallocated | 464 | ||||
| Corporate | 549 | 444 | 378 | 383 | |
| Construction Adhesives | 990 | 988 | 811 | ||
| Total | 5,183 | 4,933 | 4,724 | 4,464 | 4,275 |
Price Behavior
| Market Price | $56.02 | |
| Market Cap ($ Bil) | 3.1 | |
| First Trading Date | 03/26/1990 | |
| Distance from 52W High | -16.7% | |
| 50 Days | 200 Days | |
| DMA Price | $60.31 | $59.97 |
| DMA Trend | indeterminate | indeterminate |
| Distance from DMA | -7.1% | -6.6% |
| 3M | 1YR | |
| Volatility | 35.8% | 33.7% |
| Downside Capture | 100.80 | 110.22 |
| Upside Capture | 20.07 | 74.45 |
| Correlation (SPY) | 21.1% | 36.0% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.04 | 0.55 | 1.02 | 1.02 | 0.96 | 0.98 |
| Up Beta | 0.77 | 1.31 | 2.13 | 1.84 | 1.62 | 1.17 |
| Down Beta | 1.14 | 0.97 | 0.69 | 0.87 | 0.65 | 0.72 |
| Up Capture | -121% | -0% | 25% | 60% | 61% | 62% |
| Bmk +ve Days | 11 | 24 | 40 | 67 | 140 | 429 |
| Stock +ve Days | 10 | 22 | 34 | 62 | 123 | 367 |
| Down Capture | -17% | 31% | 74% | 91% | 99% | 103% |
| Bmk -ve Days | 10 | 17 | 23 | 58 | 112 | 321 |
| Stock -ve Days | 11 | 19 | 29 | 63 | 128 | 381 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FUL | |
|---|---|---|---|---|
| FUL | -10.0% | 33.7% | -0.27 | - |
| Sector ETF (XLB) | 12.3% | 17.6% | 0.50 | 70.2% |
| Equity (SPY) | 21.7% | 12.6% | 1.28 | 36.1% |
| Gold (GLD) | 20.5% | 27.9% | 0.65 | 24.4% |
| Commodities (DBC) | 27.3% | 18.9% | 1.14 | -27.3% |
| Real Estate (VNQ) | 13.0% | 13.9% | 0.64 | 42.2% |
| Bitcoin (BTCUSD) | -47.0% | 42.7% | -1.37 | 15.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FUL | |
|---|---|---|---|---|
| FUL | -1.2% | 29.7% | -0.02 | - |
| Sector ETF (XLB) | 6.4% | 19.1% | 0.23 | 73.7% |
| Equity (SPY) | 13.1% | 17.1% | 0.59 | 58.2% |
| Gold (GLD) | 17.2% | 18.4% | 0.76 | 12.6% |
| Commodities (DBC) | 8.6% | 19.5% | 0.33 | 5.8% |
| Real Estate (VNQ) | 2.7% | 18.9% | 0.04 | 54.3% |
| Bitcoin (BTCUSD) | 12.8% | 53.4% | 0.42 | 22.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FUL | |
|---|---|---|---|---|
| FUL | 3.8% | 31.1% | 0.18 | - |
| Sector ETF (XLB) | 10.3% | 20.6% | 0.44 | 75.8% |
| Equity (SPY) | 15.4% | 17.9% | 0.73 | 64.0% |
| Gold (GLD) | 11.2% | 16.1% | 0.57 | 5.7% |
| Commodities (DBC) | 6.3% | 18.0% | 0.27 | 18.5% |
| Real Estate (VNQ) | 5.0% | 20.7% | 0.21 | 54.9% |
| Bitcoin (BTCUSD) | 57.3% | 66.2% | 0.97 | 16.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 7/7/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 6/25/2026 | -4.1% | -11.3% | |
| 3/26/2026 | 0.5% | 10.2% | 10.8% |
| 1/15/2026 | -1.9% | -6.3% | 4.6% |
| 9/25/2025 | -3.9% | -1.1% | 2.5% |
| 6/26/2025 | 10.8% | 12.6% | 4.6% |
| 3/27/2025 | 6.1% | 6.8% | 0.5% |
| 1/16/2025 | -3.0% | -2.8% | -4.8% |
| 9/26/2024 | 0.1% | -3.1% | -6.9% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 10 | 16 |
| # Negative | 11 | 14 | 7 |
| Median Positive | 3.0% | 5.7% | 4.9% |
| Median Negative | -3.0% | -3.1% | -4.8% |
| Max Positive | 10.8% | 12.6% | 16.1% |
| Max Negative | -4.1% | -11.3% | -9.8% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 6/25/2026 | -4.1% | -11.3% | |
| 3/26/2026 | 0.5% | 10.2% | 10.8% |
| 1/15/2026 | -1.9% | -6.3% | 4.6% |
| 9/25/2025 | -3.9% | -1.1% | 2.5% |
| 6/26/2025 | 10.8% | 12.6% | 4.6% |
| 3/27/2025 | 6.1% | 6.8% | 0.5% |
| 1/16/2025 | -3.0% | -2.8% | -4.8% |
| 9/26/2024 | 0.1% | -3.1% | -6.9% |
| 6/27/2024 | 0.1% | -0.1% | 11.7% |
| 3/28/2024 | -3.4% | -6.0% | -9.8% |
| 1/18/2024 | 1.7% | 0.3% | 2.4% |
| 9/28/2023 | 6.0% | 4.0% | -3.0% |
| 6/29/2023 | 7.1% | 4.5% | 13.3% |
| 3/30/2023 | -2.0% | -4.9% | -3.0% |
| 1/19/2023 | -3.8% | -6.4% | 0.0% |
| 9/22/2022 | 3.0% | 3.3% | 5.1% |
| 6/23/2022 | -3.6% | -0.8% | 1.9% |
| 3/24/2022 | 0.7% | -0.5% | 3.0% |
| 1/20/2022 | -0.9% | -5.6% | -6.3% |
| 9/23/2021 | 7.9% | 9.6% | 15.9% |
| 6/24/2021 | -2.8% | -3.1% | -3.9% |
| 3/25/2021 | 4.6% | 7.0% | 16.1% |
| 1/26/2021 | 2.8% | 3.2% | 15.4% |
| 9/24/2020 | -1.5% | -0.8% | 7.5% |
| SUMMARY STATS | |||
| # Positive | 13 | 10 | 16 |
| # Negative | 11 | 14 | 7 |
| Median Positive | 3.0% | 5.7% | 4.9% |
| Median Negative | -3.0% | -3.1% | -4.8% |
| Max Positive | 10.8% | 12.6% | 16.1% |
| Max Negative | -4.1% | -11.3% | -9.8% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 02/28/2026 | 03/26/2026 | 10-Q |
| 11/30/2025 | 01/22/2026 | 10-K |
| 08/31/2025 | 09/25/2025 | 10-Q |
| 05/31/2025 | 06/26/2025 | 10-Q |
| 02/28/2025 | 03/27/2025 | 10-Q |
| 11/30/2024 | 01/23/2025 | 10-K |
| 08/31/2024 | 09/26/2024 | 10-Q |
| 05/31/2024 | 06/27/2024 | 10-Q |
| 02/29/2024 | 03/28/2024 | 10-Q |
| 11/30/2023 | 01/24/2024 | 10-K |
| 08/31/2023 | 09/28/2023 | 10-Q |
| 05/31/2023 | 06/29/2023 | 10-Q |
| 02/28/2023 | 03/30/2023 | 10-Q |
| 11/30/2022 | 01/24/2023 | 10-K |
| 08/31/2022 | 09/22/2022 | 10-Q |
| 05/31/2022 | 06/23/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 02/28/2026 | 03/26/2026 | 10-Q |
| 11/30/2025 | 01/22/2026 | 10-K |
| 08/31/2025 | 09/25/2025 | 10-Q |
| 05/31/2025 | 06/26/2025 | 10-Q |
| 02/28/2025 | 03/27/2025 | 10-Q |
| 11/30/2024 | 01/23/2025 | 10-K |
| 08/31/2024 | 09/26/2024 | 10-Q |
| 05/31/2024 | 06/27/2024 | 10-Q |
| 02/29/2024 | 03/28/2024 | 10-Q |
| 11/30/2023 | 01/24/2024 | 10-K |
| 08/31/2023 | 09/28/2023 | 10-Q |
| 05/31/2023 | 06/29/2023 | 10-Q |
| 02/28/2023 | 03/30/2023 | 10-Q |
| 11/30/2022 | 01/24/2023 | 10-K |
| 08/31/2022 | 09/22/2022 | 10-Q |
| 05/31/2022 | 06/23/2022 | 10-Q |
| 02/28/2022 | 03/24/2022 | 10-Q |
| 11/30/2021 | 01/25/2022 | 10-K |
| 08/31/2021 | 09/23/2021 | 10-Q |
| 05/31/2021 | 06/29/2021 | 10-Q |
| 02/28/2021 | 03/25/2021 | 10-Q |
| 11/30/2020 | 01/26/2021 | 10-K |
| 08/31/2020 | 09/24/2020 | 10-Q |
| 05/31/2020 | 06/25/2020 | 10-Q |
| 02/29/2020 | 03/26/2020 | 10-Q |
| 11/30/2019 | 01/24/2020 | 10-K |
| 08/31/2019 | 09/27/2019 | 10-Q |
| 05/31/2019 | 06/28/2019 | 10-Q |
Recent Forward Guidance
Updated 7/12/2026Latest: Q2 2026 Earnings Reported 6/25/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q3 2026 Adjusted EBITDA | 180.00 Mil | 185.00 Mil | 190.00 Mil | ||||
| 2026 Adjusted EBITDA | 650.00 Mil | 662.50 Mil | 675.00 Mil | 0.4% | Raised | Guidance: 660.00 Mil for 2026 | |
| 2026 EPS | 4.6 | 4.75 | 4.9 | 0.5% | Raised | Guidance: 4.72 for 2026 | |
| 2026 Free Cash Flow | 300.00 Mil | 312.50 Mil | 325.00 Mil | ||||
Prior: Q1 2026 Earnings Reported 3/26/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q2 2026 Adjusted EBITDA | 175.00 Mil | 180.00 Mil | 185.00 Mil | ||||
| Q2 2026 Net Revenue | |||||||
| 2026 Adjusted EBITDA | 645.00 Mil | 660.00 Mil | 675.00 Mil | 2.3% | Raised | Guidance: 645.00 Mil for 2026 | |
| 2026 Adjusted EPS | 4.55 | 4.72 | 4.9 | 4.4% | Raised | Guidance: 4.53 for 2026 | |
Q4 2025 Earnings Reported 1/15/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q1 2026 Adjusted EBITDA | 110.00 Mil | 115.00 Mil | 120.00 Mil | ||||
| 2026 Net Revenue Growth | 0.0% | 1.0% | 2.0% | 3.5% | Higher New | Actual: -2.5% for 2025 | |
| 2026 Adjusted EBITDA | 630.00 Mil | 645.00 Mil | 660.00 Mil | 4.0% | Higher New | Actual: 620.00 Mil for 2025 | |
| 2026 Depreciation and Amortization | 185.00 Mil | ||||||
| 2026 Net Interest Expense | 120.00 Mil | ||||||
| 2026 Core Tax Rate | 26.0% | 26.5% | 27.0% | ||||
| 2026 Adjusted EPS | 4.35 | 4.53 | 4.7 | 8.4% | Higher New | Actual: 4.17 for 2025 | |
| 2026 Operating Cash Flow | 275.00 Mil | 287.50 Mil | 300.00 Mil | 0.0% | Same New | Actual: 287.50 Mil for 2025 | |
| 2026 Capital Expenditures | 160.00 Mil | 14.3% | Higher New | Actual: 140.00 Mil for 2025 | |||
Insider Activity
Updated 7/10/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mastin, Celeste Beeks | President and CEO | Revocable Trust | Buy | 4072026 | 57.08 | 5,170 | 295,104 | 494,884 | Form |
| 2 | Weaver, Nathan D | Exec VP, Business Transform. | Direct | Sell | 11142025 | 58.38 | 7,075 | 413,018 | 551,138 | Form |
| 3 | Corkrean, John J | Executive VP and CFO | Direct | Sell | 10282025 | 60.31 | 14,222 | 857,764 | 3,295,837 | Form |
| 4 | East, James J | Executive Vice President, HHC | Direct | Buy | 9292025 | 58.62 | 31 | 1,817 | 165,426 | Form |
| 5 | Magalhaes, Joao | Sr. VP, Engineering Adhesives | Direct | Sell | 8112025 | 56.31 | 1,099 | 61,890 | 184,995 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mastin, Celeste Beeks | President and CEO | Revocable Trust | Buy | 4072026 | 57.08 | 5,170 | 295,104 | 494,884 | Form |
| 2 | Weaver, Nathan D | Exec VP, Business Transform. | Direct | Sell | 11142025 | 58.38 | 7,075 | 413,018 | 551,138 | Form |
| 3 | Corkrean, John J | Executive VP and CFO | Direct | Sell | 10282025 | 60.31 | 14,222 | 857,764 | 3,295,837 | Form |
| 4 | East, James J | Executive Vice President, HHC | Direct | Buy | 9292025 | 58.62 | 31 | 1,817 | 165,426 | Form |
| 5 | Magalhaes, Joao | Sr. VP, Engineering Adhesives | Direct | Sell | 8112025 | 56.31 | 1,099 | 61,890 | 184,995 | Form |
| 6 | Magalhaes, Joao | Sr. VP, Engineering Adhesives | Direct | Sell | 8082025 | 56.20 | 1,046 | 58,788 | 184,624 | Form |
| 7 | Martsching, Robert J | VP, Corporate Controller | Direct | Sell | 7112025 | 64.30 | 9,546 | 613,852 | 963,262 | Form |
Industry Resources
| Materials Resources |
| Chemical & Engineering News (C&EN) |
| Mining.com |
| Plastics News |
| Specialty Chemicals Resources |
| SpecialChem |
| Chemical Week |
| ICIS |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.